Montreal Children's Hospital is a children's hospital in Montreal, Quebec, Canada. Founded in 1904, it is affiliated with the McGill University Health Centre and McGill University, Faculty of Medicine. The hospital has 154 single-patient rooms, 52-bed neonatology unit, 6 operating rooms and 6 intervention rooms.

There are 154 beds in Montreal Children's Hospital.

During the past decade, Montreal Children's Hospital conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 68 clinical trials were completed, i.e. on average, 68.7% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 34 clinical trials were completed. i.e. 85% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montreal Children's Hospital" #1 sponsor was "Children's Oncology Group" with 70 trials, followed by "National Cancer Institute (NCI)" with 39 trials sponsored, "McGill University Health Centre/Research Institute of the McGill University Health Centre" with 32 trials sponsored, "The Hospital for Sick Children" with 9 trials sponsored and "Children's Hospital of Eastern Ontario" with 9 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montreal Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 13 trials as a collaborator, "Montreal Children's Hospital of the MUHC" with 10 trials as a collaborator, "St. Justine's Hospital" with 8 trials as a collaborator and "IWK Health Centre" with 7 trials as a collaborator. Other collaborators include 156 different institutions and companies that were collaborators in the rest 116 trials.

According to Clinical.Site data, the most researched conditions in "Montreal Children's Hospital" are "Acute Lymphoblastic Leukemia" (10 trials), "Leukemia" (7 trials), "Acute Myeloid Leukemia" (6 trials), "Recurrent Childhood Acute Lymphoblastic Leukemia" (6 trials) and "Recurrent Childhood Acute Myeloid Leukemia" (6 trials). Many other conditions were trialed in "Montreal Children's Hospital" in a lesser frequency.

Most popular intervention types in "Montreal Children's Hospital" are "Drug" (129 trials), "Other" (106 trials), "Biological" (51 trials), "Radiation" (38 trials) and "Procedure" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (48 trials), "Cyclophosphamide" (33 trials), "Vincristine Sulfate" (33 trials), "Etoposide" (24 trials) and "Doxorubicin Hydrochloride" (22 trials). Other intervention names were less common.

The vast majority of trials in "Montreal Children's Hospital" are 218 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Montreal Children's Hospital". 2 are not yet recruiting, 42 are recruiting, 53 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 97 completed trials in Montreal Children's Hospital, 2 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Montreal Children's Hospital, 18 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 29 trials that are defined as “Not Applicable".

Montreal Children's Hospital has several departments that took part in Clinical trials: "Montreal Children's Hospital at McGill University Health Center" - 71 trials